Perhaps it’s because many people have romantic and misplaced notions about nature. Some even point out that we come hard-wired with cannabinoid receptors in our brains and they must have a purpose, so why not use them? This is not exactly a persuasive argument: Nature endowed us with our own cannabinoids, so unless you have a deficiency of them or sluggish receptors, you really don’t need supplementation.
The legality of smoked cannabis and oils differs by state, with some allowing only one or the other. Likewise, some states only approved the plant for use in a limited capacity, such as for children with epileptic disorders. It continues to be classified as a Schedule I drug, making it illegal under federal stipulations. When produced from industrial hemp products, cannabis oil may be legal, but when created from a crop of medical marijuana, its status reverts back to illegal unless the state has provisions for it.
Cannabidiol is a chemical in the Cannabis sativa plant, also known as marijuana. Over 80 chemicals, known as cannabinoids, have been identified in the Cannabis sativa plant. While delta-9-tetrahydrocannabinol (THC) is the major active ingredient, cannabidiol makes up about 40% of cannabis extracts and has been studied for many different uses. According to the U.S. Food and Drug Administration (FDA), because cannabidiol has been studied as a new drug, products containing cannabidiol are not defined as dietary supplements. But there are still products labeled as dietary supplements on the market that contain cannabidiol. The amount of cannabidiol contained in these products is not always reported accurately on the product label.

Individuals are continuously suffering varying degrees of anxiety about death. We did a study on “An overview of Death Anxiety”, https://goo.gl/PvKvMJ. Method of concept analyses and an extensive online literature have been used for this study. Overall data provided evidence that anxiety about death is rife within western culture. Its prevalence, particularly with women and significant number of cases elderly people experience less death anxiety than young people.
I work well under pressure, but being extremely busy at work has almost made me less productive—I'm constantly distracted by email, Slack, and the people around me, to the point where getting my work done becomes difficult. This week, however, I've found it easier to put my blinders on, block out all distractions (especially social distractions) and focus on one task at a time. I think this is partly related to the lessened anxiety—I feel more frazzled and off task when my anxiety is running high. It almost feels like a newfound sense of clarity and calm that enables me to focus.
CBD interacts with the body through the endogenous cannabinoid system (ECS) or endocannabinoid system. First discovered in the late 1980’s, the endocannabinoid system regulates the body’s homeostasis, or general state of balance, impacting such functions as mood, sleep, appetite, hormone regulation, and pain and immune response. Like an acrobat on a highwire, as the environment around us impacts our normal balance, the endocannabinoid system “corrects” by mediating our body’s reaction to keep us level.
In this edition of Cannabis Conversations, Project CBD Director, Martin A. Lee, discusses the benefits of CBD, the "entourage effect" and the microbiome with Dr. Ethan Russo. A neurologist, scientist, and widely published author, Dr. Russo is currently the director of research and development at the International Cannabis and Cannabinoids Institute in Prague (www.icci.science).
There have been multiple clinical trials demonstrating the efficacy of nabiximols on central and peripheral neuropathic pain, rheumatoid arthritis, and cancer pain.xxiii In addition, nabiximols is currently approved in Canada for the treatment of central neuropathic pain in MS and cancer pain unresponsive to opioid therapy. However, the current evidence suggests that the analgesia is mediated by THC and it is unclear whether CBD contributes to the therapeutic effects.xxiv THC alone has been shown to reduce pain;xxv,xxvi we are unaware of clinical studies that have explored the efficacy of CBD alone on pain. However, the anti-inflammatory properties of CBD (discussed above) could be predicted to play a role in the analgesic effects of nabiximols. Recent research has also suggested that cannabinoids and opioids have different mechanisms for reducing pain and that their effects may be additive, which suggests that combination therapies may be developed that may have reduced risks compared to current opioid therapies. However, this work is very preliminary.xxvii

“Cannatonic” is one known popular CBD-rich strain which is known to contain 6.5% CBD by weight, and the same amount of THC, making for one of the most medicinal strains out there. Sour Tsunami, Ghost Rider, Harlequin, Jamaican Lion and Omrita Rx3 have been tested several times by several labs as high as 18% CBD with equal or lower percentages of THC (3:2 ratio of CBD to THC in most cases).
Phytocannabinoids are the herbal, natural and classical cannabinoids found in the cannabis plant. The glandular structure called the trichomes is where the concentrated viscous resin of the plant is found. There are over 60 cannabinoids that have been isolated from the plant. Tetrahydracannabinol (THC), Cannabidiol (CBD) and Cannabinol (CBN) are the most prevalent ones and have also been the most studied. Cannabidiol (CBD) accounts for up to 40% of the plant’s extract. It has been widely reported that CBD offers the greatest possible benefits of any of the extracts found in the plant. CBD can also be derived from hemp. Hemp and cannabis both contain large amounts of natural CBD, but hemp is naturally low in THC; thus, making it easier for manufacturers to create high CBD-infused products with low to non-existent THC levels. Since THC is (mostly) still illegal in the United States, most CBD items we carry are derived from hemp. Each CBD product varies in the amount of CBD and THC levels found in the product. No items we carry are over the legal limit of THC levels, which is 0.3%, according to U.S. Federal Law.
To be fair, the paucity of data about CBD’s efficacy and safety in part reflects the federal government’s irrational restrictions on cannabis research. Because cannabis is classified as a Schedule 1 drug, you need a license from the Drug Enforcement Administration to research it and, until two years ago, you could use only the cannabis grown at the University of Mississippi.
Another notable study conducted by Mechoulam was done on mice bred to have a version of type-1 diabetes. The diabetes was designed to manifest right around 14 weeks, so the mice were treated with CBD for the first 7 weeks of their life and then again in another 7 weeks. He concluded that only 30% had developed diabetes compared to the 90-100% given the placebo.
Marijuana can produce acute psychotic episodes at high doses, and several studies have linked marijuana use to increased risk for chronic psychosis in individuals with specific genetic risk factors. Research suggests that these effects are mediated by THC, and it has been suggested that CBD may mitigate these effects.xxxi There have been a few small-scale clinical trials in which patients with psychotic symptoms were treated with CBD, including case reports of patients with schizophrenia that reported conflicting results; a small case study in patients with Parkinson’s disease with psychosis, which reported positive results; and one small randomized clinical trial reporting clinical improvement in patients with schizophrenia treated with CBD.xxxii Large randomized clinical trials would be needed to fully evaluate the therapeutic potential of CBD for patients with schizophrenia and other forms of psychosis.

CBD Oil

×